Добірка наукової літератури з теми "Antimicrobial PEPTIDES IN VIVO"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Antimicrobial PEPTIDES IN VIVO".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Antimicrobial PEPTIDES IN VIVO"
Bals, Robert, Daniel J. Weiner, A. David Moscioni, Rupalie L. Meegalla, and James M. Wilson. "Augmentation of Innate Host Defense by Expression of a Cathelicidin Antimicrobial Peptide." Infection and Immunity 67, no. 11 (November 1, 1999): 6084–89. http://dx.doi.org/10.1128/iai.67.11.6084-6089.1999.
Повний текст джерелаSchouten, Gina, Felix Paulussen, Oscar Kuipers, Wilbert Bitter, Tom Grossmann, and Peter van Ulsen. "Stapling of Peptides Potentiates the Antibiotic Treatment of Acinetobacter baumannii In Vivo." Antibiotics 11, no. 2 (February 19, 2022): 273. http://dx.doi.org/10.3390/antibiotics11020273.
Повний текст джерелаKopeykin, P. M., M. S. Sukhareva, N. V. Lugovkina, and O. V. Shamova. "CHEMICAL SYNTHESIS AND ANALYSIS OF ANTIMICROBIAL AND HEMOLYTIC ACTIVITY OF STRUCTURAL ANALOGOUS OF A PEPTIDE PROTEGRIN 1." Medical academic journal 19, no. 1S (December 15, 2019): 169–70. http://dx.doi.org/10.17816/maj191s1169-170.
Повний текст джерелаHu, Alvin. "Conjugation of Silver Nanoparticles With De Novo–Engineered Cationic Antimicrobial Peptides: Exploratory Proposal." JMIR Research Protocols 10, no. 12 (December 8, 2021): e28307. http://dx.doi.org/10.2196/28307.
Повний текст джерелаMoser, Christian, Daniel J. Weiner, Elena Lysenko, Robert Bals, Jeffrey N. Weiser та James M. Wilson. "β-Defensin 1 Contributes to Pulmonary Innate Immunity in Mice". Infection and Immunity 70, № 6 (червень 2002): 3068–72. http://dx.doi.org/10.1128/iai.70.6.3068-3072.2002.
Повний текст джерелаYeaman, Michael R., Kimberly D. Gank, Arnold S. Bayer, and Eric P. Brass. "Synthetic Peptides That Exert Antimicrobial Activities in Whole Blood and Blood-Derived Matrices." Antimicrobial Agents and Chemotherapy 46, no. 12 (December 2002): 3883–91. http://dx.doi.org/10.1128/aac.46.12.3883-3891.2002.
Повний текст джерелаBhargavi Ram, Thimmiah, Chien Chien Belinda Tang, Siaw Fui Kiew, Sie Yon Lau, Gobi Gobi, Jeevanandam Jaison, and Michael K. Danquah. "Nanoformulation of Peptides for Pharmaceutical Applications: In Vitro and In Vivo Perspectives." Applied Sciences 12, no. 24 (December 13, 2022): 12777. http://dx.doi.org/10.3390/app122412777.
Повний текст джерелаBoullet, Héloise, Fayçal Bentot, Arnaud Hequet, Carine Ganem-Elbaz, Chérine Bechara, Emeline Pacreau, Pierre Launay, et al. "Small AntiMicrobial Peptide with In Vivo Activity Against Sepsis." Molecules 24, no. 9 (May 1, 2019): 1702. http://dx.doi.org/10.3390/molecules24091702.
Повний текст джерелаZhang, Lijuan, Jody Parente, Scott M. Harris, Donald E. Woods, Robert E. W. Hancock, and Timothy J. Falla. "Antimicrobial Peptide Therapeutics for Cystic Fibrosis." Antimicrobial Agents and Chemotherapy 49, no. 7 (July 2005): 2921–27. http://dx.doi.org/10.1128/aac.49.7.2921-2927.2005.
Повний текст джерелаRodrigues, Elaine G., Andrey S. Dobroff, Carlos P. Taborda, and Luiz R. Travassos. "Antifungal and antitumor models of bioactive protective peptides." Anais da Academia Brasileira de Ciências 81, no. 3 (September 2009): 503–20. http://dx.doi.org/10.1590/s0001-37652009000300015.
Повний текст джерелаДисертації з теми "Antimicrobial PEPTIDES IN VIVO"
Waldbrook, Matthew George. "In vivo efficacy of novel antibacterial and immunomodulatory peptides." Thesis, University of British Columbia, 2008. http://hdl.handle.net/2429/2850.
Повний текст джерелаPelillo, Chiara. "Therapeutic potential of BAC7(I-35), a Proline-rich Antimicrobial Peptide: in vitro and in vivo studies and Pegylation strategy to improve its bioavailability." Doctoral thesis, Università degli studi di Trieste, 2011. http://hdl.handle.net/10077/5978.
Повний текст джерелаThe antimicrobial peptides (AMPs) are an important component of the innate defense against invading microorganisms, are widespread in nature and may have multiple and diversified mechanisms of bactericidal action. In addition to their direct antimicrobial activity the are also involved in other biological processes. The aim of this project was to investigate the in vivo activity of Bac7(1-35), a bovine proline-rich antimicrobial peptide, having in mind its possible use as a lead compound for the development of novel anti-infective agents. Before moving to animal models of infection, the in vitro stability of the peptide in the presence of murine and human serum or plasma as well as its biodistribution in mouse were investigated. Antibacterial activity assays against Salmonella enterica showed that the presence of murine blood components largely inhibits the antibacterial activity of the peptide. On the contrary, in human serum and plasma Bac7(1-35) maintains its efficacy. This is due to the more rapid degradation by proteases of murine blood. The in vivo biodistribution of Bac7(1-35) was investigated by using a time-domain optical imaging apparatus and a fluorescently-labeled Bac7(1-35) derivative. The compound reaches the kidney and the bladder respectively 1 and 3 hours after i.p. injection. The in vivo and ex vivo analyses performed after 24 h confirm that the compound has been totally excreted. A mouse model of S. typhimurium infection was set up and used to test the therapeutic efficacy of Bac7(1-35). Treatment of infected mice with the peptide injected i.p. immediately after a lethal, intraperithoneal bacterial challenge, increased the mean survival time and reduced significantly the number of viable bacterial cells in liver and spleen of treated mice at 3 days post-inoculum. In 1/3 of the organ homogenates, the bacterial presence was undetectable and this result matches the percentage of cured animals (35%). In an attempt to improve its pharmacokinetic profile, the peptide was conjugated with polyethylene glycol (PEG), a non-toxic, non-immunogenic and FDA-approved polymer. Different strategies of pegylation have been considered to find the best method in terms of chemical yield and of maintenance of biological activity. Pegylation via a thioether ligation resulted the best strategy to obtain a slow active peptide release in human blood components with a reduced renal clearance and an increased bioavailability of Bac7(1-35), as biodistribution analyses demonstrated. Several important pathogens, such as S. enterica, cause disease by surviving and replicating within host cells. Since many AMPs have also immunomodulatory activities, we investigated the effect of Bac7(1-35) on the interaction between macrophages and Salmonella. We carried out phagocytosis assays with macrophages and the results suggest that Bac7(1-35) plays a positive modulatory effect on this function. Phagocytosis assays were also performed to determine if Bac7(1-35) could inhibit survival and replication of intracellular Salmonella. The results show that the peptide inhibits the replication of intracellular Salmonella, suggesting that it can exert its antibacterial activity within eukaryotic cells. Further studies are required to fully understand the details of the Bac7(1-35) biological activities. The results obtained provide encouraging evidence for future investigations on Bac7(1-35) and on the pegylated form Bac7(1-35)CAM-PEG20k also in other models of infection and with different intracellular pathogens.
XXIII Ciclo
1981
Silva, Osmar Nascimento. "Avaliação do potencial terapêutico e estudo da atividade imunomodulatória e antimicrobiana in vitro e in vivo de diferentes formas de clavaninas." Universidade Federal de Juiz de Fora (UFJF), 2010. https://repositorio.ufjf.br/jspui/handle/ufjf/4272.
Повний текст джерелаApproved for entry into archive by Adriana Oliveira (adriana.oliveira@ufjf.edu.br) on 2017-05-12T15:47:58Z (GMT) No. of bitstreams: 1 osmarnascimentosilva.pdf: 3091891 bytes, checksum: 8e0f2ed0de0225b3ed16c08cdd6fee62 (MD5)
Made available in DSpace on 2017-05-12T15:47:58Z (GMT). No. of bitstreams: 1 osmarnascimentosilva.pdf: 3091891 bytes, checksum: 8e0f2ed0de0225b3ed16c08cdd6fee62 (MD5) Previous issue date: 2010-02-24
CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
As infecções relacionadas à assistência à saúde (IrAS), são uma das principais causas de mortalidade e aumento dos custos hospitalares em países desenvolvidos e em desenvolvimento. Nos casos em que um paciente adquire uma IrA e esta não é tratada adequadamente, a mesma pode evoluir para um quadro mais grave, podendo levar a sepse e consequentemente na maioria dos casos a morte. A sepse representa um importante problema de saúde pública, entretanto, um tratamento eficaz para esta síndrome ainda não foi encontrado. Peptídeos antimicrobianos foram relatados para modular a resposta à infecção bacteriana na sepse, independente dos mecanismos de resistência conhecidos para os antibióticos. Desta forma, procurou-se investigar a atividade imunomodulatória de duas formas de clavaninas sobre monócitos RAW 264.7, bem como a atividade antimicrobiana e a citotoxicidade in vitro. Em ensaios in vivo a genotoxicidade, a ação das clavaninas sobre a migração de neutrófilos e a eficácia do tratamento com as clavaninas em um modelo de infecção de ferida operatória por S. aureus e sepse polimicrobiana grave também foram avaliadas. Os estudos in vitro demostraram que as clavaninas inibiram completamente o crescimento de E. coli, K. pneumoniae e S. aureus, preveniram a secreção de citocinas pró-inflamatórias (TNF-α, IL-12) e NO, e aumentaram a secreção de IL-10. Além disso, as clavaninas não apresentaram atividade citotóxica sobre as células RAW 264.7. Nos experimentos in vivo, as clavaninas não apresentaram genotoxicidade, além de apresentarem-se quimoatraentes para neutrófilos. As clavaninas, também, reduziram significativamente as unidades formadoras de colônias de S. aureus no modelo experimental de ferida operatória, e reduziram a mortalidade dos animais sépticos em mais de 50%, quando comparados com animais controle. Devido à sua ação direta sobre células do sistema imune e microorganismos, as clavaninas aparentam ser compostos potenciais para o tratamento de infecções bacterianas graves como a sepse, demonstrando alto valor biotecnológico.
Healthcare-associated infections (HAIs) are a major cause of mortality, also increasing hospital costs in developed and developing countries. When a patient acquires HAIs and this is not properly handled, disease may clearly worst, leading to sepsis and consequently in major to death. Despite of sepsis represents an important public health problem, any effective treatment for this syndrome was obtained until now. In this view, antimicrobial peptides have been reported as modulators of immune response to bacterial infection in sepsis, with independent activity of mechanisms that lead to antibiotic. Thus, the immunomodulatory activity of two different forms of clavanins over RAW 264.7 monocytes, as well the in vitro antimicrobial and cytotoxic activities were here investigated. Furthermore, in vivo genotoxicity assays, the evaluation of clavanins activity on neutrophil migration and also the efficacy of treatment with clavanins in a wound S. aureus infection model and severe polymicrobial sepsis were also evaluated. Moreover, in vitro studies demonstrated that clavanins are able of inhibit the growth of E. coli, K. pneumoniae and S. aureus. Clavanins also prevented the secretion of proinflammatory cytokines (TNF-α, IL-12) and NO, and increased the IL-10secretion. In addition, clavanins showed none cytotoxicity on RAW 264.7 cells. During in vivo experiments, the clavanins showed no genotoxicity, showing however, a clear chemotactic effect for neutrophils. Clavanins also significantly reduced the colony-forming units of S. aureus in an experimental model of surgical wound infection and reduced the mortality of septic animals in more than 50 %, when compared to control group. Due to their direct activities over immune cells and microorganisms, clavanins are potential compounds for the treatment of serious bacterial infections such as sepsis, showing an enormous and remarkable biotechnological value.
Bürkle, Carl-Philipp Stavros. "Die Expression antimikrobieller Peptide (Psoriasin, HBD-2 und HBD-3) in menschlicher Haut und deren Modulation in vivo - eine Untersuchung im xenogenen Haut-Transplantationsmodell." Doctoral thesis, Universitätsbibliothek Leipzig, 2011. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-73827.
Повний текст джерелаBorrelli, Alexander P. "Synthetic Genes for Antimicrobial Peptides." Digital WPI, 2003. https://digitalcommons.wpi.edu/etd-theses/427.
Повний текст джерелаBorelli, Alexander P. "Synthetic genes for antimicrobial peptides." Link to electronic thesis, 2003. http://www.wpi.edu/Pubs/ETD/Available/etd-0428103-102059/.
Повний текст джерелаVaucher, Rodrigo de Almeida. "Influência do peptídeo P34 na expressão gênica em Listeria spp. e estudo da citotoxicidade dos peptídeos P34 e P40." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2010. http://hdl.handle.net/10183/23977.
Повний текст джерелаIn this study initial experiments were performed to evaluate synergistic action of the antimicrobial peptide P34 and culture supernatants of some selected lactic acid bacteria isolated from Minas Frescal cheese. The influence of this peptide in the expression of genes in L. monocytogenes and L. seeligeri, their cytotoxicity in differents eukaryotic cells and “in vivo” toxicity was investigated. Also, some tests were carried out o evaluate the cytotoxicity of the antimicrobial peptide P40. The peptide P34 caused a decrease of up to 3 log cycles in viable counts of L. monocytogenes artificially inoculated in cheese. A significant increase in expression of genes dltA, Imo1695 mptA of L. monocytogenes was observed after 96 h incubation of the peptide P34 in cheese. The influence of peptide P34 on the expression of genes associated to components of cell envelope of L. monocytogenes and L. seeligeri, promoted a non significant increase in the levels of transcription of genes dltA, Imo1695 and mptA were observed after incubation of L. monocytogenes for 24 hs at 37°C and 240 hs at 4°C in plates. In L. seeligeri a significant decrease was observed in gene expression dltA. The gene Imo1695 showed a significant decrease in its expression (2000-fold) after inoculation with the peptide P34. A significant decrease of expression was also observed for the gene mptA (31872 - times) after inoculation with the peptide P34 and incubation for 24 hours at 37°C. The inoculation of the plate with the P34 peptide and incubated for 240 hrs at 4°C, showed a non-significant decrease of gene expression. The cytotoxicity of the peptide P34 and P40 was assessed in VERO cells treated with different concentrations (0.02 - 2.5 μg ml- 1). In MTT, NRU and LDH assays the EC50 to the peptide P34 were 0.60, 1.25, 0.65 μg ml-1 and the peptide P40 were 0.30, 0.51 and 0.57 μg ml-1, respectively. The hemolytical activity on human erythrocytes was of (5.8%) and (19%), respectively. The effects on viability, motility and acrosomal exocytosis of humam sperm were also evaluated for peptideP34. There were no hypersensitivity reactions or significant increase in antibody titer during the immunogenicity experiment or death of animals during the acute or subchronic toxicity tests. The LD50 was more the 332.3 ± 0.76 mg/kg. No significant changes in the serum biochemical parameters were observed in the animals treated with the peptide P34. Signs of possible toxicity were no detected in animals in the group treated with 0.825 mg/kg day of peptide P34. In this group only histological changes in the spleen with the presence of megakaryocytes were observed. From these results show the potential o peptide P34 to be used in future as biopreservative in foods.
Vargues, Thomas. "Antimicrobial peptides : structure, function and resistance." Thesis, University of Edinburgh, 2009. http://hdl.handle.net/1842/4076.
Повний текст джерелаZhao, Hongxia. "Mode of action of antimicrobial peptides." Helsinki : University of Helsinki, 2003. http://ethesis.helsinki.fi/julkaisut/laa/biola/vk/zhao/.
Повний текст джерелаParisi, Rosaura. "Computational design of new antimicrobial peptides." Doctoral thesis, Universita degli studi di Salerno, 2018. http://hdl.handle.net/10556/3018.
Повний текст джерелаAntimicrobial peptides (AMP) are evolutionarily conserved components of the innate immune system. They have a broad spectrum of action against bacteria, fungi and viruses. Therefore, AMP are studied as probable substitutes of the traditional antibiotics, for which most pathogens have developed resistance. The main objective of this work was the design of novel linear peptides capable to interact with the cellular membrane of the common pathogens. In this work, sequences of active AMP were carefully obtained from the scientific literature and collected in Yadamp (http://yadamp.unisa.it/), a database of AMP created recently in the laboratory where this project was carried out. In Yadamp, there are information about peptides name, amino acid sequence, length, presence of disulfide bridges, date of discovery, activity and taxonomy. The most relevant chemical-physical properties are also listed. This database is mainly focused on the peptides activities. Experimental MIC values (the lowest concentration of an antimicrobial that inhibits the visible growth of a microorganism) are constantly obtained from careful reading the original papers. In this work, a great contribution was made in the enrichment of the database. In fact, 1009 sequences were added to Yadamp. It currently contains 3142 AMP sequences. For these AMP, 573 molecular descriptors were calculated. In addition, this project also involved the search for new molecular descriptors. Yadamp is a resource for QSAR investigations on AMP. It allows to create subsets of AMP, homogeneous in one, two or more parameters...[abstract by Author]
XXX ciclo
Книги з теми "Antimicrobial PEPTIDES IN VIVO"
Hansen, Paul R., ed. Antimicrobial Peptides. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-6737-7.
Повний текст джерелаMatsuzaki, Katsumi, ed. Antimicrobial Peptides. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-3588-4.
Повний текст джерелаPhoenix, David A., Sarah R. Dennison, and Frederick Harris. Antimicrobial Peptides. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2013. http://dx.doi.org/10.1002/9783527652853.
Повний текст джерелаGiuliani, Andrea, and Andrea C. Rinaldi, eds. Antimicrobial Peptides. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-594-1.
Повний текст джерелаHarder, Jürgen, and Jens-M. Schröder, eds. Antimicrobial Peptides. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-24199-9.
Повний текст джерелаJoan, Marsh, Goode Jamie, Ciba Foundation, and Symposium on Antimicrobial Peptides (1994 : Ciba Foundation)d), eds. Antimicrobial peptides. Chichester, Eng: Wiley, 1994.
Знайти повний текст джерелаDrider, Djamel, and Sylvie Rebuffat, eds. Prokaryotic Antimicrobial Peptides. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-7692-5.
Повний текст джерелаHiemstra, Pieter S., and Sebastian A. J. Zaat, eds. Antimicrobial Peptides and Innate Immunity. Basel: Springer Basel, 2013. http://dx.doi.org/10.1007/978-3-0348-0541-4.
Повний текст джерелаShafer, William M., ed. Antimicrobial Peptides and Human Disease. Berlin, Heidelberg: Springer Berlin Heidelberg, 2006. http://dx.doi.org/10.1007/3-540-29916-5.
Повний текст джерелаAntimicrobial peptides: Methods and protocols. New York: Humana Press/Springer, 2010.
Знайти повний текст джерелаЧастини книг з теми "Antimicrobial PEPTIDES IN VIVO"
Afacan, Nicole J., Laure M. Janot, and Robert E. W. Hancock. "Host Defense Peptides: Immune Modulation and Antimicrobial Activity In Vivo." In Antimicrobial Peptides and Innate Immunity, 321–58. Basel: Springer Basel, 2012. http://dx.doi.org/10.1007/978-3-0348-0541-4_13.
Повний текст джерелаKolar, Satya Sree, Hasna Baidouri, Maria Luisa Mangoni, and Alison M. McDermott. "Methods for In Vivo/Ex Vivo Analysis of Antimicrobial Peptides in Bacterial Keratitis: siRNA Knockdown, Colony Counts, Myeloperoxidase, Immunostaining, and RT-PCR Assays." In Methods in Molecular Biology, 411–25. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-6737-7_30.
Повний текст джерелаPark, Andrew J., Jean-Phillip Okhovat, and Jenny Kim. "Antimicrobial Peptides." In Clinical and Basic Immunodermatology, 81–95. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-29785-9_6.
Повний текст джерелаChakraborti, Srinjoy, and Sanjay Ram. "Antimicrobial Peptides." In Management of Infections in the Immunocompromised Host, 95–113. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-77674-3_5.
Повний текст джерелаMarcos, Jose F., and Paloma Manzanares. "Antimicrobial Peptides." In Antimicrobial Polymers, 195–225. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2011. http://dx.doi.org/10.1002/9781118150887.ch8.
Повний текст джерелаJack, Ralph W., Gabriele Bierbaum, and Hans-Georg Sahl. "Antimicrobial Peptides." In Lantibiotics and Related Peptides, 1–39. Berlin, Heidelberg: Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-662-08239-3_1.
Повний текст джерелаLata, Sneh, and Gajendra Raghava. "Antimicrobial Peptides." In Encyclopedia of Systems Biology, 31–33. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-9863-7_87.
Повний текст джерелаGanz, T., and R. I. Lehrer. "Antimicrobial Peptides." In Handbook of Experimental Pharmacology, 295–304. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-55742-2_16.
Повний текст джерелаSørensen, Ole E. "Antimicrobial Peptides in Cutaneous Wound Healing." In Antimicrobial Peptides, 1–15. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-24199-9_1.
Повний текст джерелаZasloff, Michael. "Antimicrobial Peptides: Do They Have a Future as Therapeutics?" In Antimicrobial Peptides, 147–54. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-24199-9_10.
Повний текст джерелаТези доповідей конференцій з теми "Antimicrobial PEPTIDES IN VIVO"
Kašperová, Alena, Jaroslav Turánek, Václav Čeřovský, and Milan Raška. "In vitro and in vivo antimicrobial effect of lasioglossins on the Candida albicans." In XIIth Conference Biologically Active Peptides. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2011. http://dx.doi.org/10.1135/css201113054.
Повний текст джерелаTůmová, Tereza, Petra Lovecká, Václav Čeřovský, and Jiřina Slaninová. "Real time in vivo monitoring of cytotoxic activity of two different antimicrobial peptides lasioglossin III and lasiocepsin." In XIIth Conference Biologically Active Peptides. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2011. http://dx.doi.org/10.1135/css201113151.
Повний текст джерелаLammi, Carmen. "From the bench to the bedside: the history of lupin bioactive peptides as useful ingredient for the prevention of metabolic syndrome." In 2022 AOCS Annual Meeting & Expo. American Oil Chemists' Society (AOCS), 2022. http://dx.doi.org/10.21748/bwgm4089.
Повний текст джерелаKrasnodembskaya, Anna, Yuanlin Song, Jae-Woo Lee, and Michael A. Matthay. "Human Mesenchymal Stem Cells Exert Antimicrobial Activity In Vitro And In Vivo In Part Through The Secretion Of The Antimicrobial Peptide LL-37." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1246.
Повний текст джерелаTuránek, Jaroslav, Michaela Škrabalová, and Pavlína Knötigová. "Antimicrobial and anticancer peptides." In XIth Conference Biologically Active Peptides. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2009. http://dx.doi.org/10.1135/css200911128.
Повний текст джерелаKaygorodova, I. A. "ANTIMICROBIAL PEPTIDES OF PARASITIC LEECHES." In ECOLOGICAL PROBLEMS OF LAKE BAIKAL BASIN. Buryat Scientific Center of SB RAS Press, 2022. http://dx.doi.org/10.31554/978-5-7925-0621-3-2022-59-61.
Повний текст джерелаČeřovský, Václav, Rudolf Ježek, Vladimír Fučík, and Jiřina Slaninová. "Antimicrobial peptides from the venom of Vespidae." In Xth Conference Biologically Active Peptides. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2007. http://dx.doi.org/10.1135/css200709025.
Повний текст джерелаDoležílková, Ivana, Martina Macková, and Tomáš Macek. "Short peptides with antimicrobial activity from plants." In XIth Conference Biologically Active Peptides. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2009. http://dx.doi.org/10.1135/css200911025.
Повний текст джерелаEhala, Sille, Petr Niederhafner, Václav Čeřovský, Pavel Řezanka, David Sýkora, Vladimír Král, and Václav Kašička. "Analysis of antimicrobial peptides by capillary electrophoresis." In XIIth Conference Biologically Active Peptides. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2011. http://dx.doi.org/10.1135/css201113037.
Повний текст джерелаBo, Shi-ru, Jiang-hua Yu, Ya-li Wang, and Quan-kai Wang. "Preparation and Antimicrobial Activity of Antimicrobial Peptides from Plum Deer Antler." In 2017 5th International Conference on Mechatronics, Materials, Chemistry and Computer Engineering (ICMMCCE 2017). Paris, France: Atlantis Press, 2017. http://dx.doi.org/10.2991/icmmcce-17.2017.142.
Повний текст джерелаЗвіти організацій з теми "Antimicrobial PEPTIDES IN VIVO"
Doherty, Laurel A., Morris Slutsky, and Jason W. Soares. Antimicrobial Peptides with Differential Bacterial Binding Characteristics. Fort Belvoir, VA: Defense Technical Information Center, March 2013. http://dx.doi.org/10.21236/ada577726.
Повний текст джерелаMierswa, S. C., T. H. Lee, and M. C. Yung. Developing an engineered therapeutic microbe to release antimicrobial peptides (AMPs). Office of Scientific and Technical Information (OSTI), August 2019. http://dx.doi.org/10.2172/1558856.
Повний текст джерелаYung, M. C. Engineering a therapeutic microbe for site-of-infection delivery of encapsulated antimicrobial peptides (AMPs). Office of Scientific and Technical Information (OSTI), October 2019. http://dx.doi.org/10.2172/1573149.
Повний текст джерелаVouros, Paul, and Terrance Black. Solid Phase Peptide Synthesis of Antimicrobial Peptides for cell Binding Studies: Characterization Using Mass Spectrometry. Fort Belvoir, VA: Defense Technical Information Center, November 2002. http://dx.doi.org/10.21236/ada412571.
Повний текст джерелаNoga, Edward J., Angelo Colorni, Michael G. Levy, and Ramy Avtalion. Importance of Endobiotics in Defense against Protozoan Ectoparasites of Fish. United States Department of Agriculture, September 2003. http://dx.doi.org/10.32747/2003.7586463.bard.
Повний текст джерелаAltstein, Miriam, and Ronald Nachman. Rationally designed insect neuropeptide agonists and antagonists: application for the characterization of the pyrokinin/Pban mechanisms of action in insects. United States Department of Agriculture, October 2006. http://dx.doi.org/10.32747/2006.7587235.bard.
Повний текст джерелаDroby, Samir, Michael Wisniewski, Martin Goldway, Wojciech Janisiewicz, and Charles Wilson. Enhancement of Postharvest Biocontrol Activity of the Yeast Candida oleophila by Overexpression of Lytic Enzymes. United States Department of Agriculture, November 2003. http://dx.doi.org/10.32747/2003.7586481.bard.
Повний текст джерелаAltstein, Miriam, and Ronald J. Nachman. Rational Design of Insect Control Agent Prototypes Based on Pyrokinin/PBAN Neuropeptide Antagonists. United States Department of Agriculture, August 2013. http://dx.doi.org/10.32747/2013.7593398.bard.
Повний текст джерела